Stock Evaluator: Guardian Pharmacy Services, Inc. (GRDN)

Guardian Pharmacy Services, Inc. GRDN

$39.53 -1.67 -4.05%
July 31, 2026 4:00:02 PM EST November 10, 2021 Volume: 429,539
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Commentary & Analysis


Financial Summary

Share Statistics GRDN Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $2,608.8 $1,875.0 57%
Shares Out (Mil) 63.7 77.1 54%
Institutional Ownership 73.2% 88.9% 44%
Float (Mil) 32.0 50.3 38%
Beta na 0.86 na
Avg Daily Volume (000s) 290 466 50%
Price Change
(52-week)
102.7% 78.5% 92%
Growth GRDN Industry
Median
Percentile
(All Stocks)
Sales (5yr) 14.5% 10.9% 72%
Net Income (5yr) 19.8% (1.1%) 73%
EPS (5yr) na 3.0% na
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) na (18.2%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 6 6 6
Current EPS $0.262 $1.260 $1.358
Month Ago EPS $0.262 $1.260 $1.358
# Rev Up 2 2 3
# Rev Down 0 0 0
Three Months Ago EPS $0.263 $1.225 $1.348
Year/Year Chg 25.4% 62.0% 93.7%
Financials GRDN Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1,456 $1,464 56%
Net Income (TTM) (Mil) $53 $15 56%
EPS (TTM) $0.846 $0.300 59%
Operating Cash Flow (TTM) (Mil) $89 $138 52%
Net Cash Flow (TTM) (Mil) $51 $7 71%
Long-Term Debt (Q1) (Mil) $34 $323 36%
Enterprise Value (Q1) (Mil) $2,424 $2,130 52%
Valuation GRDN Industry
Median
Percentile
(All Stocks)
P/B 11.81 2.90 91%
P/E 49.3 26.8 83%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios GRDN Industry
Median
Percentile
(All Stocks)
Gross Margin 20.9% 27.6% 22%
Net Margin 3.6% 1.1% 44%
ROA 13.9% 1.8% 93%
ROE 28.2% 6.9% 86%
Liabilities to Assets 45.6% 60.0% 37%
F-Score 5 5 51%

Guardian Pharmacy Services, Inc. did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors